Steven Weitman, M.D., Ph.D.
Professor of Pediatrics
Director of the Institute for Drug Development
Joint Appointment in Pharmacology and Medicine
Steve obtained his M.D. and Ph.D. at the Medical College of Wisconsin. He is a Pediatric Hematology/Oncologist with about 25 years of experience in cancer drug development. Steve is currently Professor at the Institute for Drug Development at UT Health San Antonio. He was previously Chief Medical Officer, Senior Vice President, and Member of the Executive Committee at ILEX Oncology where he led ILEX’s successful development of clofarabine (Clolar™) and guided that product through a successful ODAC and FDA approval. He also worked on the FDA approval of pralatrexate and romidepsin as well as the post-approval commitments for campath. Steve is inventor on numerous patents and author of over 200 papers, abstracts and chapters in the medical literature. Steve is also a consultant to various biotech and pharmaceutical companies, past Associate Editor of Investigational New Drugs and reviewer for multiple journals including the American Journal of Pediatric Hematology/Oncology, Clinical Cancer Research, Cancer Research and the Journal of Clinical Oncology.
-
Professional Background
Education
- 1987 - M.D. - Medicine - Medical College of Wisconsin, Milwaukee, WI
- 1985 - Ph.D. - Pharmacology - Medical College of Wisconsin, Milwaukee, WI
- 1984 - M.S. - Pharmacology - Medical College of Wisconsin, Milwaukee, WI
- 1978 - B.S. - Microbiology - University of Wisconsin-LaCrosse, LaCrosse, WI
-
- Publications